Literature DB >> 26643897

Development of a Method for Profiling Protein Interactions with LNA-Modified Antisense Oligonucleotides Using Protein Microarrays.

Satoko Kakiuchi-Kiyota1, Lawrence O Whiteley2, Anne M Ryan1, Nagappan Mathialagan1.   

Abstract

Development of locked nucleic acid (LNA) gapmers, antisense oligonucleotides used for efficient inhibition of target RNA expression, is limited by nontarget-mediated hepatotoxicity. Increased binding of hepatocellular proteins to toxic LNA gapmers may be one of the mechanisms contributing to LNA gapmer-induced hepatotoxicity in vivo. In the present study, we investigated the protein binding propensity of nontoxic sequence-1 (NTS-1), toxic sequence-2 (TS-2), and severely highly toxic sequence-3 (HTS-3) LNA gapmers using human protein microarrays. We previously demonstrated by the transcription profiling analysis of liver RNA isolated from mice that TS-2 and HTS-3 gapmers modulate different transcriptional pathways in mice leading to hepatotoxicity. Our protein array profiling demonstrated that a greater number of proteins, including ones associated with hepatotoxicity, hepatic system disorder, and cell functions, were bound by TS-2 and HTS-3 compared with NTS-1. However, the profiles of proteins bound by TS-2 and HTS-3 were similar and did not distinguish proteins contributing to severe in vivo toxicity. These results, together with the previous transcription profiling analysis, indicate that the combination of sequence-dependent transcription modulation and increased protein binding of toxic LNA gapmers contributes to hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26643897     DOI: 10.1089/nat.2015.0576

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  7 in total

1.  Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs.

Authors:  Piotr J Kamola; Klio Maratou; Paul A Wilson; Kay Rush; Tanya Mullaney; Tom McKevitt; Paula Evans; Jim Ridings; Probash Chowdhury; Aude Roulois; Ann Fairchild; Sean McCawley; Karen Cartwright; Nigel J Gooderham; Timothy W Gant; Kitty Moores; Stephen A Hughes; Mark R Edbrooke; Kenneth Clark; Joel D Parry
Journal:  Mol Ther Nucleic Acids       Date:  2017-07-08       Impact factor: 8.886

2.  Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins.

Authors:  Michael T Migawa; Wen Shen; W Brad Wan; Guillermo Vasquez; Michael E Oestergaard; Audrey Low; Cheryl L De Hoyos; Ruchi Gupta; Susan Murray; Michael Tanowitz; Melanie Bell; Joshua G Nichols; Hans Gaus; Xue-Hai Liang; Eric E Swayze; Stanley T Crooke; Punit P Seth
Journal:  Nucleic Acids Res       Date:  2019-06-20       Impact factor: 16.971

3.  mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway.

Authors:  Xue-Hai Liang; Joshua G Nichols; Chih-Wei Hsu; Timothy A Vickers; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

4.  Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs.

Authors:  Sabine Sewing; Franziska Boess; Annie Moisan; Cristina Bertinetti-Lapatki; Tanja Minz; Maj Hedtjaern; Yann Tessier; Franz Schuler; Thomas Singer; Adrian B Roth
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

5.  Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia.

Authors:  Sabine Sewing; Adrian B Roth; Michael Winter; Andreas Dieckmann; Cristina Bertinetti-Lapatki; Yann Tessier; Claudia McGinnis; Sylwia Huber; Erich Koller; Corinne Ploix; John C Reed; Thomas Singer; Andreas Rothfuss
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

6.  Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.

Authors:  Wen Shen; Cheryl L De Hoyos; Hong Sun; Timothy A Vickers; Xue-Hai Liang; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

7.  In vitro inhibition of porcine reproductive and respiratory syndrome virus replication by short antisense oligonucleotides with locked nucleic acid modification.

Authors:  Lingyun Zhu; Junlong Bi; Longlong Zheng; Qian Zhao; Xianghua Shu; Gang Guo; Jia Liu; Guishu Yang; Jianping Liu; Gefen Yin
Journal:  BMC Vet Res       Date:  2018-03-26       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.